ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer. Passaro A, Leighl N, Blackhall F, Popat S, et al. Ann Oncol 2022 Feb 14. pii: S0923-7534(22)00112.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Passaro A, Leighl N, Blackhall F, Popat S, et al. ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer. Ann Oncol 2022 Feb 14. pii: S0923-7534(22)00112.
PMID: 35176458